U.S. Poison Centers save $3.1 billion every year in medical costs and lost productivity, according to a new independent study released by America’s Poison Centers®. Conducted by RAND, the report confirms that U.S. Poison Centers provide substantial economic and societal benefits for communities across the country. In 2025, the Oklahoma Poison Center managed 31,462 human exposure cases and handled a total of 36,167 incoming calls, including 4,580 informational calls. To ensure patient safety and continuity of care, specialists conducted 34,335 follow-up calls, resulting in more than 70,500 total calls answered and placed in support of Oklahoma families and health care providers.

The University of Oklahoma College of Pharmacy hosted its Annual Pharmacy Alumni Reception on June 12, honoring outstanding alumni and celebrating the college’s achievements.

Two hundred and twelve University of Oklahoma students eligible to participate in graduation ceremonies maintained a perfect 4.0 grade-point average throughout their academic program at OU. Of the total, 140 reside in Oklahoma.

The University of Oklahoma Health Sciences recently announced the opening of more than 29,100 square feet of new laboratory space at University Research Park in Oklahoma City. The innovative facility represents an $11 million investment in OU’s strategic plan to become a top-tier research-driven academic health center.

The chemotherapy drug cisplatin is a lifesaver for many adults and children diagnosed with cancer, but it often causes hearing loss, a side effect that can diminish quality of life following treatment. To prevent hearing damage during cancer treatment, a University of Oklahoma researcher created a novel drug delivery system that transports medications to the inner ear; her studies about the promising innovation are published in the Journal of Controlled Release and the Journal of Nanobiotechnology.